With new investment records set across the board, it is the golden era of healthcare in China due to robust government support, sweeping regulatory changes, a strong talent base and more. Review the report compiled by ChinaBio® Group that uncovers the activity in 2018. Read the latest analysis of life science investment activity to get ahead for ChinaBio® Partnering Forum in Shanghai, May 8-9!
Topics Include:
- VC Funds Raised
- VC Investment
- M&A Activity
- IPOs
- Partnering Activity
Get a sneak peek at the 2018 investment activity in China from the report. New records were set across the board!
Source: ChinaBio® Consulting